Thryv Therapeutics Inc.

📍 Montréal, Canada🗓 Founded 2019👥 24 employees💰 Last funded Jan 2024
Biotechnology Research
LinkedIn
Thryv Therapeutics Inc. (previously LQT Therapeutics Inc.) is a privately owned company based in Montreal, Quebec, Canada. Thryv Therapeutics is pioneering a precision medicine approach to treat genetic and drug-induced Long QT Syndromes, atrial fibrillation, and resistant cancers with potent and selective inhibitors of Serum Glucocorticoid inducible Kinase. For more information, please visit www.thryvtrx.com.
4
Total investors
3
Early stage
1
Mid stage
0
Late stage
2019
Founded

Investors

4 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Canada
4
Investor activity2020–2024 · investors recorded per year
202012021220241
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Thryv Therapeutics Inc.?
Thryv Therapeutics Inc. has 4 investors on record on gritt.io, including 3 early-stage backers, 1 mid-stage.
When did Thryv Therapeutics Inc. last raise funding?
The most recent investment in Thryv Therapeutics Inc. recorded on gritt.io was in January 2024.
When was Thryv Therapeutics Inc. founded?
Thryv Therapeutics Inc. was founded in 2019.
What industry is Thryv Therapeutics Inc. in?
Thryv Therapeutics Inc. operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Thryv Therapeutics Inc. based?
Thryv Therapeutics Inc. is headquartered in Montréal, Canada.